Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With RAS/BRAF Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial
曲妥珠单抗联合帕妥珠单抗对比西妥昔单抗联合伊立替康治疗 RAS/BRAF 野生型、HER2 阳性转移性结直肠癌患者(S1613):一项随机 II 期试验
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-24-01710
Raghav, Kanwal Pratap Singh; Guthrie, Katherine A; Tan, Benjamin Jr; Denlinger, Crystal S; Fakih, Marwan; Overman, Michael J; Dasari, N Arvind; Corum, Larry R; Hicks, Lee G; Patel, Mital S; Esparaz, Benjamin T; Kazmi, Syed M; Alluri, Nitya; Colby, Sarah; Gholami, Sepideh; Gold, Philip J; Chiorean, E Gabriela; Kopetz, Scott; Hochster, Howard S; Philip, Philip A